1,956 Synopsys, Inc. $SNPS Shares Purchased by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS raised its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 96.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,979 shares of the semiconductor company’s stock after buying an additional 1,956 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Synopsys were worth $1,731,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Elevation Wealth Partners LLC raised its stake in shares of Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after acquiring an additional 27 shares during the last quarter. Osbon Capital Management LLC acquired a new position in shares of Synopsys in the 2nd quarter worth approximately $25,000. IMG Wealth Management Inc. bought a new stake in Synopsys during the 2nd quarter worth approximately $28,000. GK Wealth Management LLC bought a new stake in Synopsys during the 3rd quarter worth approximately $28,000. Finally, EFG International AG acquired a new stake in Synopsys during the 2nd quarter valued at $34,000. 85.47% of the stock is owned by institutional investors.

Insider Transactions at Synopsys

In other Synopsys news, insider Janet Lee sold 1,144 shares of the business’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total transaction of $574,882.88. Following the completion of the sale, the insider directly owned 16,534 shares of the company’s stock, valued at approximately $8,308,665.68. The trade was a 6.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the company’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the transaction, the chief financial officer owned 22,717 shares in the company, valued at approximately $11,358,500. The trade was a 28.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 117,163 shares of company stock worth $51,366,457 in the last ninety days. 0.56% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Morgan Stanley lifted their price objective on Synopsys from $500.00 to $574.00 and gave the company an “overweight” rating in a research report on Tuesday, October 20th. Barclays assumed coverage on Synopsys in a report on Friday, September 25th. They set an “overweight” rating on the stock. JPMorgan Chase & Co. decreased their target price on Synopsys from $650.00 to $600.00 in a report on Thursday, August 27th. Wells Fargo & Company raised their target price on Synopsys from $475.00 to $540.00 and gave the company an “overweight” rating in a research note on Thursday, October 1st. Finally, Needham & Company LLC lifted their price target on Synopsys from $580.00 to $620.00 and gave the company a “buy” rating in a report on Monday, October 12th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and a consensus target price of $575.00.

Get Our Latest Stock Report on Synopsys

Synopsys Stock Performance

SNPS stock opened at $466.97 on Tuesday. The company has a 50 day moving average price of $442.10 and a 200 day moving average price of $442.00. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The stock has a market capitalization of $89.49 billion, a PE ratio of 82.50, a price-to-earnings-growth ratio of 1.47 and a beta of 1.18.

Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The business’s quarterly revenue was up 42.4% compared to the same quarter last year. During the same period last year, the company earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts forecast that Synopsys, Inc. will post 11.01 EPS for the current year.

Synopsys declared that its Board of Directors has authorized a stock buyback plan on Monday, October 5th that allows the company to buy back $1 billion in shares. This repurchase authorization allows the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.

Synopsys Profile

(Free Report)

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

See Also

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.